DV
Dividend Vision

NAGE — Niagen Bioscience, Inc.

Niagen Bioscience, Inc. (NAGE)

Total return is -74.2% over the past 18.1 years, 793.0 points behind SPY at 718.8%. Its deepest 1-year drawdown was 71.1%.

Niagen Bioscience, Inc. is a bioscience company that develops and commercializes healthy aging products, operating through consumer products, ingredients, and pharmaceutical segments. The company manufactures and sells dietary supplements containing its proprietary NAD+ precursor ingredient nicotinamide riboside under the NIAGEN brand, distributing finished products directly to consumers via its e-commerce platform and retail partners, while also supplying raw ingredient materials to manufacturers. The company does not currently distribute dividends.

NAGE key facts

Asset type
Stock
Asset class
Equity
Inception date
06/25/2008
Last close
$3.02
Market cap
$268,401,376
Average volume
390900.0
Beta
2.083
Payout ratio
0.0
P/E ratio
15.3182
Forward P/E
12.6103
EPS
$0.22